Drug:
Reaction: PRURITUS
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26945439 |
US |
67 | 2 |
Pruritus, Erythema, |
||||
ABATACEPT, ABATACEPT, |
||||
| 102 | 26945464 |
US |
33 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 103 | 26945472 |
US |
2 | |
Pruritus, |
||||
SARILUMAB, |
||||
| 104 | 26945498 |
US |
2 | |
Feeling of body temperature change, Burning sensation, Fatigue, Nausea, Abdominal pain, Pruritus, Headache, Arthralgia, Bone pain, Arthralgia, Pruritus, Injection site swelling, Injection site pain, Injection site haemorrhage, Ocular discomfort, Dizziness, Product packaging issue, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, POTASSIUM CHLORIDE, PANTOPRAZOLE, PROMETHAZINE HYDROCHLORIDE, TIZANIDINE, CYANOCOBALAMIN, |
||||
| 105 | 26945582 |
US |
56 | 2 |
Pruritus, |
||||
SPARSENTAN, |
||||
| 106 | 26945610 |
US |
2 | |
Urticaria, Heart rate irregular, Condition aggravated, Injection site pain, Tachycardia, Pruritus, Heart rate increased, Dizziness, Fatigue, |
||||
ABALOPARATIDE, |
||||
| 107 | 26945628 |
US |
56 | 1 |
Pruritus, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 108 | 26945634 |
US |
||
Night sweats, Splenomegaly, Hepatic enzyme increased, Asthenia, Fatigue, Pruritus, |
||||
RUXOLITINIB, ROPEGINTERFERON ALFA-2B, ROPEGINTERFERON ALFA-2B, ARIPIPRAZOLE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FENOFIBRATE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, TIRZEPATIDE, |
||||
| 109 | 26945637 |
2 | ||
Road traffic accident, Intentional dose omission, Contusion, Pruritus, |
||||
TEZEPELUMAB-EKKO, ONABOTULINUMTOXINA, |
||||
| 110 | 26945685 |
US |
2 | |
Blister, Blister rupture, Neck pain, Anxiety, Injection site discomfort, Injection site haemorrhage, Back pain, Pruritus, Drug ineffective, |
||||
ABALOPARATIDE, RIMEGEPANT SULFATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, PROMETHAZINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 111 | 26945770 |
US |
73 | 2 |
Insomnia, Palpitations, Pruritus, Intentional product misuse, Therapy interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 112 | 26945801 |
US |
2 | |
Chills, Dry skin, Paraesthesia, Headache, Nausea, Tachycardia, Pruritus, Insomnia, Product use in unapproved indication, |
||||
ABALOPARATIDE, ABALOPARATIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ERGOCALCIFEROL, CALCIUM, HYDROXYCHLOROQUINE SULFATE, LEUCOVORIN CALCIUM, PREDNISONE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 113 | 26945827 |
US |
2 | |
Dry skin, Pruritus, Abdominal distension, |
||||
ABALOPARATIDE, |
||||
| 114 | 26945843 |
US |
67 | 2 |
Flushing, Mouth swelling, Local reaction, Erythema, Papule, Injection site pain, Injection site erythema, Pruritus, Product dose omission in error, |
||||
ABALOPARATIDE, |
||||
| 115 | 26945850 |
US |
82 | 2 |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 116 | 26945943 |
US |
53 | 1 |
Pruritus, Anxiety, Dyspnoea, Night sweats, Feeling abnormal, Nightmare, |
||||
SPARSENTAN, |
||||
| 117 | 26945965 |
US |
2 | |
Blood iron increased, Hypertension, Muscle spasms, Orthostatic hypotension, Back pain, Malaise, Urticaria, Abdominal discomfort, Nausea, Fatigue, Pruritus, Circumstance or information capable of leading to medication error, Needle issue, Drug ineffective, Product dose omission issue, Inappropriate schedule of product administration, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, CEFDINIR, PREDNISONE, CALCIUM, |
||||
| 118 | 26945996 |
US |
2 | |
Erythema, Skin burning sensation, Condition aggravated, Pruritus, |
||||
ABALOPARATIDE, |
||||
| 119 | 26946106 |
US |
71 | 1 |
Skin burning sensation, Pruritus, Rash, Erythema, |
||||
LENALIDOMIDE, |
||||
| 120 | 26946177 |
US |
59 | 1 |
Pruritus, Peripheral swelling, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 121 | 26946200 |
US |
62 | 2 |
Rash papular, Injection site erythema, Pruritus, Headache, Injection site pain, Needle issue, |
||||
ABALOPARATIDE, PREDNISONE, |
||||
| 122 | 26946218 |
US |
2 | |
Eosinophil percentage increased, Eosinophil count increased, White blood cell count increased, Injection site bruising, Constipation, Rash, Pruritus, Injection site reaction, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, CALCIUM, ERGOCALCIFEROL, VORTIOXETINE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 123 | 26946229 |
US |
44 | 2 |
Pruritus, Hypersensitivity, |
||||
SPARSENTAN, |
||||
| 124 | 26946264 |
US |
2 | |
Erythema, Urticaria, Pruritus, |
||||
ABALOPARATIDE, |
||||
| 125 | 26946286 |
US |
42 | 1 |
Pruritus, Inflammation, |
||||
| 126 | 26946293 |
GB |
7 | 1 |
Lip swelling, Swelling face, Oropharyngeal pain, Pruritus, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, BECLOMETHASONE DIPROPIONATE, |
||||
| 127 | 26946338 |
US |
66 | 2 |
Pruritus, Urinary tract infection, Eczema, |
||||
DUPILUMAB, |
||||
| 128 | 26946352 |
US |
70 | 2 |
Burning sensation, Blood pressure increased, Rash, Pruritus, Muscle spasms, Injection site swelling, |
||||
ABALOPARATIDE, |
||||
| 129 | 26946430 |
US |
74 | 2 |
Fracture, Umbilical erythema, Abdominal symptom, Cough, Swelling, Pruritus, |
||||
ABALOPARATIDE, |
||||
| 130 | 26946439 |
US |
63 | 2 |
Rash erythematous, Pruritus, |
||||
ABALOPARATIDE, |
||||
| 131 | 26946499 |
US |
23 | 2 |
Pruritus, Musculoskeletal chest pain, |
||||
SPARSENTAN, |
||||
| 132 | 26946730 |
US |
2 | |
Pruritus, Dry skin, |
||||
SPARSENTAN, |
||||
| 133 | 26946741 |
CA |
67 | 1 |
Haemoglobin decreased, Off label use, Platelet count decreased, White blood cell count decreased, Thrombocytopenia, Pruritus, |
||||
TEMOZOLOMIDE, ELTROMBOPAG, ELTROMBOPAG OLAMINE, ELTROMBOPAG, ELTROMBOPAG OLAMINE, ELTROMBOPAG, ELTROMBOPAG OLAMINE, ELTROMBOPAG, ELTROMBOPAG OLAMINE, PANTOPRAZOLE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CYANOCOBALAMIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 134 | 26946775 |
US |
2 | |
Burning sensation, Headache, Rash, Pruritus, |
||||
ABALOPARATIDE, |
||||
| 135 | 26946823 |
US |
73 | 2 |
Paraesthesia, Inflammation, Swelling, Pruritus, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 136 | 26946840 |
US |
2 | |
Stress, Erythema, Skin burning sensation, Pruritus, |
||||
ABALOPARATIDE, ABALOPARATIDE, RISANKIZUMAB-RZAA, |
||||
| 137 | 26947043 |
US |
59 | 2 |
Dry skin, Pruritus, |
||||
ABALOPARATIDE, |
||||
| 138 | 26947057 |
US |
2 | |
Injection site mass, Pruritus, Injection site erythema, |
||||
ABALOPARATIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, FISH OIL, |
||||
| 139 | 26947201 |
US |
2 | |
Urticaria, Pruritus, Dyspnoea, |
||||
ABALOPARATIDE, LOSARTAN POTASSIUM, LOSARTAN, ROSUVASTATIN CALCIUM, |
||||
| 140 | 26947294 |
US |
2 | |
Drug intolerance, Pruritus, Intentional product misuse, |
||||
ABALOPARATIDE, |
||||
| 141 | 26947302 |
US |
2 | |
Urticaria, Back pain, Pruritus, |
||||
ABALOPARATIDE, |
||||
| 142 | 26947335 |
US |
2 | |
Carpal tunnel decompression, Illness, Injection site pain, Nausea, Pruritus, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, GABAPENTIN, GABAPENTIN, IRON, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DIAZEPAM, VITAMIN C, OXYBUTYNIN, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, |
||||
| 143 | 26947377 |
US |
2 | |
Urticaria, Skin mass, Pruritus, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 144 | 26947564 |
US |
2 | |
Pain in jaw, Dyspepsia, Insomnia, Pain, Abdominal distension, Pruritus, Abdominal pain, |
||||
ABALOPARATIDE, |
||||
| 145 | 26947604 |
US |
58 | |
Pruritus, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 146 | 26947609 |
US |
2 | |
Abdominal discomfort, Pruritus, Nausea, Vomiting, Dizziness, Headache, Product administered at inappropriate site, |
||||
ABALOPARATIDE, |
||||
| 147 | 26947685 |
US |
77 | 1 |
Cough, Pruritus, Dry skin, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 148 | 26947709 |
US |
2 | |
Dizziness, Nausea, Pruritus, Dry skin, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ORAL SEMAGLUTIDE, |
||||
| 149 | 26947713 |
US |
2 | |
Skin burning sensation, Rash, Pruritus, Product use in unapproved indication, |
||||
ABALOPARATIDE, ABALOPARATIDE, GUSELKUMAB, |
||||
| 150 | 26947783 |
US |
33 | 1 |
Pruritus, |
||||
BIMEKIZUMAB, |
||||
| 151 | 26947791 |
US |
2 | |
Adverse drug reaction, Swelling face, Skin mass, Pruritus, |
||||
ABALOPARATIDE, |
||||
| 152 | 26947952 |
US |
87 | 2 |
Dermatitis atopic, Stress, Pruritus, |
||||
DUPILUMAB, |
||||
| 153 | 26947954 |
US |
57 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 154 | 26947955 |
US |
13 | 2 |
Injection site pain, Pruritus, Skin fissures, Skin haemorrhage, |
||||
DUPILUMAB, |
||||
| 155 | 26947991 |
US |
2 | |
Erythema, Pruritus, Fear of injection, |
||||
ABALOPARATIDE, |
||||
| 156 | 26948009 |
US |
71 | |
Pruritus, Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 157 | 26948044 |
US |
78 | 2 |
Skin lesion, Skin burning sensation, Condition aggravated, Pruritus, Circumstance or information capable of leading to medication error, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 158 | 26948191 |
US |
2 | |
Musculoskeletal stiffness, Superficial vein prominence, Joint swelling, Palpitations, Pruritus, Device use issue, |
||||
ABALOPARATIDE, |
||||
| 159 | 26948254 |
US |
2 | |
Feeling of body temperature change, Sensory disturbance, Night sweats, Pruritus, |
||||
ABALOPARATIDE, |
||||
| 160 | 26951045 |
80 | 1 | |
Burning sensation, Pruritus, |
||||
| 161 | 26952105 |
60 | 2 | |
Pruritus, |
||||
BOSUTINIB, |
||||
| 162 | 26934082 |
US |
50 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 163 | 26934094 |
CA |
69 | 1 |
Arthritis, Hypoaesthesia, Oxygen saturation decreased, Product use issue, Thermal burn, Weight decreased, Body temperature decreased, Insomnia, Weight increased, Dry eye, Micturition disorder, Oedema peripheral, Ligament rupture, Blood pressure increased, Nerve compression, Gingival ulceration, Musculoskeletal stiffness, Blood pressure fluctuation, Pain in extremity, Joint range of motion decreased, Arthralgia, Blood pressure decreased, Mass, Infusion related reaction, Rash, Skin abrasion, Peripheral swelling, Pain, Dysuria, Paraesthesia, Skin papilloma, Blood pressure diastolic decreased, Dry skin, Neck pain, Skin discolouration, Blood pressure systolic increased, Cystitis bacterial, Blood pressure diastolic abnormal, Inflammation, Mouth ulceration, Fall, Anaemia, Rib fracture, Drug ineffective, Musculoskeletal stiffness, Back pain, Ill-defined disorder, Blood pressure systolic abnormal, Heart rate decreased, Pruritus, Osteoarthritis, Dry throat, Arthralgia, Arthralgia, Arthralgia, Pain, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CELECOXIB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, FOLIC ACID, |
||||
| 164 | 26934105 |
CA |
44 | 2 |
Arthropathy, Pruritus, Rash, Pain, Duodenal ulcer perforation, Alopecia, Discomfort, Abdominal discomfort, Contusion, Sinusitis, Anti-cyclic citrullinated peptide antibody positive, |
||||
DICLOFENAC, DICLOFENAC SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, ALENDRONATE SODIUM, |
||||
| 165 | 26934117 |
CA |
19 | 2 |
Duodenal ulcer perforation, Swollen joint count increased, Fatigue, Musculoskeletal stiffness, Lung disorder, Autoimmune disorder, Wound, Dyspnoea, Pericarditis, Pruritus, Nasopharyngitis, Infusion related reaction, Liver injury, Condition aggravated, Ill-defined disorder, Malaise, Hepatic enzyme increased, Drug intolerance, Lower respiratory tract infection, Arthralgia, Hypersensitivity, Discomfort, Hypertension, Contusion, Sciatica, Anti-cyclic citrullinated peptide antibody positive, Therapy non-responder, Pemphigus, Psoriatic arthropathy, Joint swelling, Osteoarthritis, Sleep disorder due to general medical condition, insomnia type, Lip dry, Pain, Gastrointestinal disorder, Helicobacter infection, Night sweats, Lower limb fracture, Mobility decreased, Alopecia, C-reactive protein, Stomatitis, Folliculitis, Treatment failure, Weight increased, Rheumatoid arthritis, Confusional state, Rash, Rheumatic fever, Deep vein thrombosis postoperative, Infection, Type 2 diabetes mellitus, Pyrexia, Oedema, Blister, Liver disorder, Urticaria, Injury, Systemic lupus erythematosus, |
||||
PREGABALIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, APREMILAST, RITUXIMAB, RITUXIMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, DICLOFENAC, DICLOFENAC SODIUM, TRAMADOL HYDROCHLORIDE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, OXYCODONE, OXYCODONE, PREDNISONE, PREDNISONE, ALENDRONATE SODIUM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, CELECOXIB, ABATACEPT, ABATACEPT, ABATACEPT, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ADALIMUMAB, ADALIMUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, NEOMYCIN OINTMENT, LEFLUNOMIDE, ETANERCEPT, ETANERCEPT, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, PREDNISONE, GOLIMUMAB, GOLIMUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, MELOXICAM, QUETIAPINE FUMARATE, QUETIAPINE, ERGOCALCIFEROL, MAGNESIUM HYDROXIDE, SULFASALAZINE, LISINOPRIL, VITAMIN C, ACETAMINOPHEN AND CODEINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PIROXICAM, ERGOCALCIFEROL, CAFFEINE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RAMIPRIL, LANSOPRAZOLE, ERGOCALCIFEROL, RISEDRONATE SODIUM, LORAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 166 | 26934188 |
74 | ||
Throat tightness, Erythema, Pruritus, Palpitations, Rash, |
||||
METOPROLOL TARTRATE, LEVOTHYROXINE SODIUM, |
||||
| 167 | 26934287 |
US |
60 | 1 |
Dry skin, Skin fissures, Pruritus, |
||||
DUPILUMAB, |
||||
| 168 | 26934294 |
US |
3 | 1 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 169 | 26934298 |
US |
23 | 2 |
Idiopathic urticaria, Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 170 | 26934304 |
US |
57 | 2 |
Urticaria, Pruritus, Skin swelling, Erythema, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 171 | 26934505 |
|||
Pruritus, |
||||
BENAZEPRIL HYDROCHLORIDE, |
||||
| 172 | 26934535 |
US |
2 | |
Pruritus, |
||||
FEZOLINETANT, FEZOLINETANT, |
||||
| 173 | 26934552 |
GB |
84 | 2 |
Nausea, Diarrhoea, Bone pain, Pruritus, Vomiting, Rash, Blister, Arthralgia, Pain in extremity, |
||||
DENOSUMAB, |
||||
| 174 | 26934570 |
US |
73 | 2 |
Skin burning sensation, Pruritus, Drug ineffective, Rash, |
||||
DUPILUMAB, |
||||
| 175 | 26934589 |
US |
20 | 2 |
Pruritus, Dry skin, Skin exfoliation, Off label use, |
||||
DUPILUMAB, |
||||
| 176 | 26934601 |
US |
2 | 2 |
Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 177 | 26934603 |
US |
72 | 1 |
Pruritus, |
||||
DUPILUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, DESONIDE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, LATANOPROST, LOSARTAN POTASSIUM, LOSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 178 | 26934605 |
US |
23 | 2 |
Eczema, Pruritus, Rash, Product preparation error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 179 | 26934610 |
US |
33 | 1 |
Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 180 | 26934765 |
JP |
38 | 2 |
Injection site erythema, Injection site induration, Pruritus, Erythema, |
||||
GARADACIMAB, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, ZOLPIDEM TARTRATE, DULOXETINE HYDROCHLORIDE, DULOXETINE, PREGABALIN, SENNOSIDES, FAMOTIDINE, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, OMALIZUMAB, |
||||
| 181 | 26934774 |
BR |
49 | 2 |
Carcinoembryonic antigen increased, Colorectal cancer metastatic, Acne pustular, Fatigue, Eye irritation, Lacrimation increased, Pruritus, Erythema, Nausea, Somnolence, Pigmentation disorder, Dysuria, Malaise, Oral discomfort, Dysgeusia, Restlessness, Feeding disorder, Food intolerance, Skin haemorrhage, Skin fissures, Skin burning sensation, Urine abnormality, Memory impairment, Dysphagia, |
||||
PANITUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 182 | 26934824 |
CA |
2 | |
Duodenal ulcer perforation, Wound, Stomatitis, Blister, Irritable bowel syndrome, Condition aggravated, Pain, Infection, Ill-defined disorder, Sinusitis, Folliculitis, Injury, Sleep disorder due to general medical condition, insomnia type, Glossodynia, Pyrexia, Swelling, Arthropathy, Synovitis, Muscle injury, Nasopharyngitis, Confusional state, Sleep disorder, Rheumatoid arthritis, Pericarditis, Joint swelling, Infusion related reaction, General physical health deterioration, Systemic lupus erythematosus, Impaired healing, Peripheral swelling, Contusion, Alopecia, Arthralgia, Lower respiratory tract infection, Fatigue, Pemphigus, Gastrointestinal disorder, Anti-cyclic citrullinated peptide antibody positive, Hand deformity, Hepatic enzyme increased, Weight increased, Discomfort, Abdominal discomfort, Helicobacter infection, Rash, Hypersensitivity, Pruritus, Dyspnoea, Insomnia, Contraindicated product administered, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALENDRONATE SODIUM, ALENDRONATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, RITUXIMAB, LEFLUNOMIDE, OXYCODONE, TOFACITINIB CITRATE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, APREPITANT, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CERTOLIZUMAB PEGOL, FOLIC ACID, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, ADALIMUMAB, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, INFLIXIMAB, ABATACEPT, SULFASALAZINE, LEFLUNOMIDE, DESOGESTREL AND ETHINYL ESTRADIOL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 183 | 26934842 |
US |
28 | 2 |
Pruritus, Dry skin, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 184 | 26934848 |
US |
43 | 1 |
Pruritus, Swelling, Condition aggravated, Injection site pain, |
||||
DUPILUMAB, |
||||
| 185 | 26934860 |
US |
32 | 2 |
Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 186 | 26934865 |
US |
45 | 2 |
Injection site pain, Skin irritation, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 187 | 26934873 |
US |
3 | 2 |
Pruritus, Dermatitis, |
||||
DUPILUMAB, |
||||
| 188 | 26934877 |
US |
52 | 2 |
Pruritus, Dry skin, Skin exfoliation, Insomnia, |
||||
DUPILUMAB, |
||||
| 189 | 26934881 |
EU |
2 | |
Thrombocytopenia, Rectal haemorrhage, Gastrointestinal obstruction, Mitral valve incompetence, Asthenia, Nausea, Constipation, Gastrointestinal disorder, Frequent bowel movements, Infection, Back pain, Haemorrhoids, Urticaria, Dyspnoea exertional, Sacral pain, Diastolic dysfunction, Anorectal discomfort, Anal fissure, Pruritus, |
||||
BEVACIZUMAB, |
||||
| 190 | 26934927 |
US |
2 | |
Pruritus, Rash, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 191 | 26935056 |
BR |
2 | |
Skull fracture, Haemorrhoids, Carcinoembryonic antigen increased, Liver injury, Metastasis, Metastases to bone, Metastases to liver, Metastases to spine, Metastases to thorax, Metastases to thyroid, Breast cancer metastatic, Metastases to liver, Haemorrhage, Skin fissures, Face injury, Dry throat, Dry skin, Rectocele, Nasal dryness, Vulvovaginal dryness, Skin exfoliation, Nasal discomfort, Contusion, Vascular rupture, Clavicle fracture, Panic attack, Blood oestrogen decreased, Skin disorder, Skin atrophy, Pain, Injury, Bone neoplasm, Limb injury, Peripheral swelling, Skin discolouration, Hypokinesia, Movement disorder, Limb discomfort, Muscular weakness, Lymphadenopathy, Stress, Erythema, Feeling abnormal, Gastrooesophageal reflux disease, Gait disturbance, Quality of life decreased, Rhinitis, Fatigue, Bone pain, Abdominal pain upper, PIK3CA-activated mutation, Hepatic mass, Nodule, Brain fog, Weight decreased, Insomnia, Greater trochanteric pain syndrome, Dry eye, Urinary tract infection, Arthralgia, Rash macular, Pain in extremity, Epistaxis, Alopecia, Hypersensitivity, Haematoma, Pruritus, Erythema, Tumour marker increased, Injection site swelling, Drug intolerance, Dizziness, Vomiting, Head discomfort, Malaise, Constipation, Polyp, Retching, Nausea, Dehydration, Sinusitis, Eating disorder, Thermal burn, Skin lesion, Hiatus hernia, Sensory loss, Drug ineffective, Needle issue, |
||||
FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, PANTOPRAZOLE, ANASTROZOLE, ANASTROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, ZOLEDRONIC ACID, ZOLEDRONIC ACID, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ALPELISIB, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, CLONAZEPAM, EXEMESTANE, |
||||
| 192 | 26935086 |
US |
7 | 2 |
Pruritus, Dry skin, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 193 | 26935088 |
US |
49 | 1 |
Pruritus, Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 194 | 26935091 |
US |
61 | 1 |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 195 | 26935094 |
US |
18 | 2 |
Knee operation, Pruritus, Neurodermatitis, |
||||
DUPILUMAB, |
||||
| 196 | 26935107 |
US |
65 | 2 |
Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 197 | 26935117 |
US |
69 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 198 | 26935139 |
|||
Pruritus, Formication, Adverse drug reaction, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, PERMETHRIN, PERMETHRIN CREAM 5% W/W, |
||||
| 199 | 26935234 |
US |
2 | |
Pruritus, |
||||
OLODATEROL RESPIMAT INHALATION SPRAY, |
||||
| 200 | 26935276 |
US |
1 | |
Brain fog, Urticaria, Pruritus, |
||||
ROPEGINTERFERON ALFA-2B, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
